HOME >> BIOLOGY >> NEWS
Portable kidney dialysis machine developed

CORVALLIS A Portland company is using an emerging microtechnology from Oregon State University to develop a portable kidney dialysis machine that will make in-home treatment a reality, enabling hundreds of thousands of people afflicted with kidney failure to treat themselves at home instead of traveling to dialysis clinics three days a week.

"Current dialysis machines are based on 30-year-old technology and employ filter systems that are only about 28 percent efficient," said Michael Baker, chief executive officer of Home Dialysis Plus, the firm developing the device.

"By employing the microtechnology being developed at OSU's College of Engineering, the filter efficiency skyrockets to about 90 percent," Baker said. "And we're able to reduce the dimensions of a dialysis machine from the size of a refrigerator to the size of a piece of carry-on luggage, which makes treatment portable."

Baker said that more than 600 jobs could be associated with the device when production begins.

OSU researchers and Home Dialysis Plus officials say the reduced size and increased efficiency will improve the lives of dialysis patients because treatments will be done in the home while patients are asleep at night. Many dialysis patients now have to limit travel and other opportunities due to time-consuming treatments that can take up to four hours.

"A growing number of studies indicate that longer and/or more frequent in-home dialysis offers not only superior therapy, but also the opportunity to reduce costs," Baker said. "These revelations are prompting more and more dialysis patients to demand the health benefits, the convenience, and the quality of life that in-home dialysis has to offer. We launched Home Dialysis Plus to give dialysis patients the life-improving technology they've been asking for."

Home Dialysis Plus was founded by Altman Browning and Company, a Portland product development firm that has been working closely with researchers at the OSU C
'"/>

Contact: Ron Adams
ronald.lynn.adams@oregonstate.edu
541-737-3101
Oregon State University
2-Feb-2004


Page: 1 2 3 4

Related biology news :

1. Portable unit created to treat wastewater in remote locations
2. Iron can have negative side effects on people with kidney disease
3. Newly grown kidneys can sustain life in rats
4. Fox Chase Cancer Center research shows kidney cancer can be diagnosed in urine
5. UT Southwestern researchers discover link that could aid in treatment of kidney cyst diseases
6. Patients give nod to kidney dialysis at home
7. Early identification of kidney disease cost-effective only when directed at high-risk patients
8. Fox Chase Cancer Center research shows kidney cancer can be diagnosed in urine
9. Severe kidney disease in blacks linked to genes on two chromosomes
10. Sugar coupled to protein causes kidneys to save water
11. Obesity, kidney genetics, erectile dysfunction among highlighted research at APS Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Portable kidney dialysis machine developed

(Date:7/2/2015)... Research and Markets( http://www.researchandmarkets.com/research/jvft55/next_generation ) has ... Market by Application, Technology, Function & Geography - Global ... The next generation biometrics market is expected to ... 17.9% between 2015 and 2020 Travel & ... Safran SA ( France ), NEC ...
(Date:6/30/2015)... June 30, 2015 Genisphere announced ... CEO to help further develop Genisphere,s therapeutics capabilities and ... experience, having spent much of the last 25 years ... Baxter Bioscience, and Johnson & Johnson. Tom started his ... and Biotech Corporate Finance. He graduated from Dartmouth College ...
(Date:6/25/2015)... , June 25, 2015 ... Market by Type (Swipe & Area), Technology, Material (Optical ... Healthcare, Commercial Security & Others) & Geography - ... marketsandmarkets, the said market is expected to reach ... 17.1%. Browse 76 market Tables ...
Breaking Biology News(10 mins):Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4
(Date:7/30/2015)... Denmark , July 30, 2015 ... biotechnology company that applies its innovative TransCon technology ... positive top-line results from a six-month Phase 2 ... once-weekly TransCon Growth Hormone in 53 treatment-naïve, pre-pubertal ... "We are extremely pleased with the top-line ...
(Date:7/30/2015)... , ... July 30, 2015 , ... As part of its 2015 growth plan and ... and technical service business units, Whitehouse Laboratories is pleased to announce that it ... to the Container Center of Excellence and will be strictly dedicated to basic USP 51, ...
(Date:7/29/2015)... , July 30, 2015 ... la santé, publie ses résultats pour le premier ... commente les résultats. Visionner l,interview ... http://www.eurobusinessmedia.com/ceo-direct/sanofi/sanofi-h1-2015-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire Au sommaire de ... - Moteurs de croissance - ...
(Date:7/29/2015)... (Q2 2015: +14% CER / 20% of sales) led the regional performance in ... , as well as solid contributions from Korea, India ... Middle East / Africa (Q2 2015: ... , Turkey and the United Kingdom ... excluding U.S. HPV sales, on demand across all customer classes. The top seven ...
Breaking Biology Technology:Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7Whitehouse Labs Formally Announces Plans to Open a Microbiological Laboratory 2QIAGEN Reports Results for Second Quarter and First Half of 2015 2QIAGEN Reports Results for Second Quarter and First Half of 2015 3QIAGEN Reports Results for Second Quarter and First Half of 2015 4QIAGEN Reports Results for Second Quarter and First Half of 2015 5QIAGEN Reports Results for Second Quarter and First Half of 2015 6QIAGEN Reports Results for Second Quarter and First Half of 2015 7QIAGEN Reports Results for Second Quarter and First Half of 2015 8QIAGEN Reports Results for Second Quarter and First Half of 2015 9QIAGEN Reports Results for Second Quarter and First Half of 2015 10
Cached News: